News
NAII
6.56
+0.92%
0.06
Weekly Report: what happened at NAII last week (0408-0412)?
Weekly Report · 3d ago
Weekly Report: what happened at NAII last week (0401-0405)?
Weekly Report · 04/08 12:04
NATURAL ALTERNATIVES INTERNATIONAL SCHEDULED TO REOPEN U.S. MANUFACTURING FACILITY IN CALIFORNIA TO SUPPORT INCREASED PRODUCTION NEEDS
Reuters · 04/02 13:00
Weekly Report: what happened at NAII last week (0325-0329)?
Weekly Report · 04/01 12:01
Weekly Report: what happened at NAII last week (0318-0322)?
Weekly Report · 03/25 12:04
Weekly Report: what happened at NAII last week (0311-0315)?
Weekly Report · 03/18 12:02
Naturl Alt Intl: Statement of changes in beneficial ownership of securities
Press release · 03/11 22:27
Weekly Report: what happened at NAII last week (0304-0308)?
Weekly Report · 03/11 11:58
Weekly Report: what happened at NAII last week (0226-0301)?
Weekly Report · 03/04 12:01
Weekly Report: what happened at NAII last week (0219-0223)?
Weekly Report · 02/26 12:19
Weekly Report: what happened at NAII last week (0212-0216)?
Weekly Report · 02/19 12:22
Natural Alternatives Intl Q2 EPS $(0.52) Down From $0.31 YoY, Sales $25.20M Down From $42.30M YoY
Natural Alternatives Intl reported quarterly losses of $0.52 per share. The company reported $25.20 million in sales this quarter. This is a 40.42 percent decrease over sales of the same period last year. Natural Alternatives reported a 267.74 percent decrease in sales for the quarter.
Benzinga · 02/13 21:47
*Natural Alternatives: We Now Expect to Generate a Net Loss in 2H of FY24 and an Overall Net Loss in FY24 >NAII
Dow Jones · 02/13 21:33
*Natural Alternatives 2Q Sales $25.2M >NAII
Dow Jones · 02/13 21:30
Press Release: Natural Alternatives International, Inc. Announces 2024 Q2 and YTD Results
Natural Alternatives International, Inc. Announces 2024 Q2 and YTD Results. The company reported a net loss of $3.1 million for the second quarter of fiscal year 2024. Private-label contract manufacturing sales decreased 44% to $25.2 million. CarnoSyn(R) beta-alanine royalty, licensing and raw material sales revenue increased 48%.
Dow Jones · 02/13 21:30
Press Release: Natural Alternatives -2-
For the three months ending December 31, 2016, and June 30, 2017, the company reported a total of $155.7 million in cash and cash equivalents. The company has a long-term commitment to buy back shares of the common stock of the company at a ratio of 1.1 to 1. The total number of shares outstanding for the company as of December 31 is $15.6 million. The company's total assets for the quarter ended June 30 are $55.9 million. For the year, total assets are $155 million.
Dow Jones · 02/13 21:30
*Natural Alternatives 2Q Loss $3.07M >NAII
Dow Jones · 02/13 21:30
*Natural Alternatives 2Q Loss/Shr 52c >NAII
Dow Jones · 02/13 21:30
Natural Alternatives: Fiscal Q2 Earnings Snapshot
Natural Alternatives International Inc. Reported a loss of $3.1 million in its fiscal second quarter. The nutritional supplements manufacturer posted revenue of $25.2 million in the period. Carlsbad, California-based company said it had loss of 52 cents per share.
Barchart · 02/13 15:51
Weekly Report: what happened at NAII last week (0205-0209)?
Weekly Report · 02/12 12:07
More
Webull provides a variety of real-time NAII stock news. You can receive the latest news about Naturl Alt Intl through multiple platforms. This information may help you make smarter investment decisions.
About NAII
Natural Alternatives International, Inc. is a formulator, manufacturer and marketer of nutritional supplements. The Company operates through two segments: Private-label contract manufacturing, and Royalty, licensing, and raw material. The Private-label contract manufacturing segment primarily provides manufacturing services to companies that market and distribute nutritional supplements and other health care products. Royalty, licensing, and raw material segment associated with the sale and license of beta-alanine under the Company’s CarnoSyn and SR CarnoSyn trademarks. The Company provides private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal and other nutritional supplements as well as other health care products. It private-label contract manufacturing customers include companies that market nutritional supplements through direct sales marketing channels, direct to consumer e-commerce channels, and retail stores.